Endoxifen clinical trials
Includes 3 studies of Endoxifen hydrochloride.
How each study uses endoxifen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the endoxifen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
10 studies that test it; most in 2011 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2015 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 6
National Cancer Institute (NCI) (4) · Atossa Therapeutics, Inc. (4) · QuantumLeap Healthcare Collaborative (2) · Jina Pharmaceuticals Inc. (1)
Often tested with
Tested in the same studies.
Tamoxifen (1) · Anastrozole (1) · Testosterone (1) · Elacestrant (1) · Trastuzumab (1) · Ganitumab (1) · Ado-Trastuzumab Emtansine (1) · Pertuzumab (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test endoxifen.
- Nov 2026(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerPhase 2 · Atossa Therapeutics, Inc.
Studies
Open first, then newest update. How each study uses endoxifen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentRecruitingPhase 2QuantumLeap Healthcare CollaborativeNCT06075953Written as Z-endoxifen
- (Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious PubertyNot yet recruitingPhase 2Atossa Therapeutics, Inc.NCT07869732Written as (Z)-endoxifen
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerRecruitingPhase 2QuantumLeap Healthcare CollaborativeNCT01042379Written as Z-endoxifen
- Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast SurgeryActive, not recruitingPhase 1National Cancer Institute (NCI)NCT03317405Written as Endoxifen Hydrochloride
- Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerActive, not recruitingPhase 2National Cancer Institute (NCI)NCT02311933Written as Endoxifen Hydrochloride
- Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast CancerActive, not recruitingPhase 1National Cancer Institute (NCI)NCT01327781Written as Endoxifen Hydrochloride
- (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerActive, not recruitingPhase 2Atossa Therapeutics, Inc.NCT05607004Written as (Z)-endoxifen
- Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast DensityCompletedPhase 2Atossa Therapeutics, Inc.NCT05068388Written as Z-Endoxifen
- Endoxifen in Adults With Hormone Receptor Positive Solid TumorsCompletedPhase 1National Cancer Institute (NCI)NCT01273168Written as Z-Endoxifen
- Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder PatientsCompletedPhase 3Jina Pharmaceuticals Inc.NCT04315792Written as Endoxifen
- Topical Endoxifen in WomenCompletedPhase 2Atossa Therapeutics, Inc.NCT04616430Written as Topical endoxifen
Codes
What other systems call endoxifen · ClinicalTrials.gg INT003372
- MeSH (NLM) C0554924-hydroxy-N-desmethyltamoxifenConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 46AF8680RCENDOXIFENConfirmed FDA, NLM, Wikidata
- Wikidata Q27149598endoxifenConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C221983EndoxifenOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C055492 | 4-hydroxy-N-desmethyltamoxifen | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 46AF8680RC | ENDOXIFEN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27149598 | endoxifen | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C221983 | Endoxifen | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.